Targeting base excision repair as a sensitization strategy in radiotherapy

Area of Science:

• Oncology
• Molecular Biology
• Radiation Oncology

Background:

• Cellular DNA repair is crucial for survival following ionizing radiation exposure.
• Human tumors frequently display aberrant DNA repair, contributing to mutagenesis and chromosomal instability.
• Alterations in base excision repair (BER) and single strand break repair (SSBR) pathways are increasingly reported in human cancers.

Purpose of the Study:

• To review recent findings on BER and SSBR pathway alterations in human tumors.
• To discuss the implications of these aberrations for radiation sensitivity.
• To explore strategies for targeting tumor-specific DNA repair defects to enhance radiotherapy efficacy.

Main Methods:

• Literature review of recent reports on DNA repair pathways in human tumors.
• Analysis of the relationship between BER/SSBR aberrations and cellular radiation resistance.
• Examination of therapeutic strategies aimed at counteracting or exploiting these DNA repair alterations.

Main Results:

• Aberrant BER and SSBR pathways in tumors can significantly influence cellular resistance to radiation and other therapeutic agents.
• These DNA repair defects can be exploited to develop tumor-specific radiosensitization strategies.
• Targeting these aberrations may increase the therapeutic window by selectively sensitizing tumor cells while sparing normal tissues.

Conclusions:

• Tumor-specific alterations in base excision repair (BER) and single strand break repair (SSBR) pathways represent a critical factor in determining radiosensitivity.
• Targeting these aberrant DNA repair mechanisms offers promising avenues for enhancing radiotherapy efficacy.
• Exploiting tumor-dependent DNA repair pathways can lead to improved therapeutic outcomes in cancer treatment.